Should platelet transfusion be used to reverse preinjury antiplatelet agents in traumatic brain injury? A systematic review and meta-analysis.
The journal of trauma and acute care surgery · 2026-01-12 · Meta-analysis
Abstract
INTRODUCTION: Platelet transfusion is a scarce resource in many trauma centers that is not without its own complications. Controversy exists in the literature regarding platelet transfusion in the setting of traumatic brain injury in patients on antiplatelet agents. METHODS: A search of the MEDLINE and Cochrane Reviews databases was used to identify all studies examining platelet transfusion and antiplatelet agents related to traumatic brain injury published from inception to March 2024. Study selection, data extraction, and bias assessment were conducted independently by two reviewers. Heterogeneity was assessed via I2 statistic, and publication bias was evaluated using Newcastle Ottawa Scale for cohort studies. A meta-analysis was performed to estimate pooled treatment effects with 95% confidence intervals (CIs). RESULTS: Of the 131 studies initially identified, 11 studies met the inclusion criteria comprising 1,326 patients who received platelet transfusion and 5,391 patients who did not. Across studies, patients receiving platelets were more severity injured than those who did not (mean Glasgow Coma Scale, 13.4 ± 0.44 vs. 14.2 ± 0.26; mean Injury Severity Score, 20.7 ± 0.9 vs. 18 ± 3.4). Pooled analysis found that receiving platelet transfusion did not significantly change the likelihood of mortality or hemorrhage progression (odds ratio, 1.40; 95% CI, 0.72-2.71; odds ratio, 1.09; 95% CI, 0.37-3.20, respectively). Both length of stay (LOS) and intensive care unit LOS were found to be significantly longer with platelet transfusion (2.2 days longer: 95% CI, 2.07-2.32; 3.06 days longer: 95% CI, 2.0-4.13). CONCLUSION: The results currently available in the literature do not support the routine reversal of preinjury antiplatelet agents for reducing mortality or hemorrhage progression. Furthermore, the use of platelet transfusion in these patients may unnecessarily prolong intensive care unit and hospital LOS. This meta-analysis provides justification for randomized-controlled trials investigating the effects of platelet transfusion in head-injured patients on preinjury antiplatelet agents. Obtaining higher level of evidence will expedite the creation of high-quality evidence-based guidelines for the management of these complex patients. LEVEL OF EVIDENCE: Systematic Review/Meta-analysis; Level IV.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antithrombotics & thrombolytics · Blood products · Fluids & blood · Mortality & survival
Related articles
- Early plasma administration in traumatic brain injuries: A systematic review. (Transfusion, 2026)
- Crystalloid volume is associated with short-term morbidity in children with severe traumatic brain injury: An Eastern Association for the Surgery of Trauma multicenter trial post hoc analysis. (J Trauma Acute Care Surg, 2023)
- Association of Prehospital Plasma With Survival in Patients With Traumatic Brain Injury: A Secondary Analysis of the PAMPer Cluster Randomized Clinical Trial. (JAMA Netw Open, 2020)
- The development and feasibility of a remote damage control resuscitation prehospital plasma transfusion protocol for warfarin reversal for patients with traumatic brain injury. (Transfusion, 2013)
- Transfusion of red blood cells in patients with a prehospital Glasgow Coma Scale score of 8 or less and no evidence of shock is associated with worse outcomes. (J Trauma Acute Care Surg, 2013)
- Enhanced prehospital volume therapy does not lead to improved outcomes in severely injured patients with severe traumatic brain injury. (BMC Emerg Med, 2019)